BEAM vs VRTX
BEAM 与 VRTX 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | BEAMBeam Therapeutics Inc. | VRTXVERTEX PHARMACEUTICALS INC / MA |
|---|---|---|
| 市值 | $2.85B | $138.99B |
| 市盈率(TTM) | — | 35.3 |
| 市净率 | 3.00 | 6.65 |
| 市销率 | 20.3x | 11.6x |
| 营收 | $146.64M(TTM) | $12.95B(TTM) |
| 营收同比增长 | 120.0% | 8.9% |
| 净利润 | -$108.35M(TTM) | $3.98B(TTM) |
| 净利同比增长 | 78.8% | 838.1% |
| 每股收益(稀释) | $-0.88(TTM) | $15.54(TTM) |
| 息税前利润率 | -274.6% | 34.8% |
| 净资产收益率 | -8.4% | 18.9% |
| 投入资本回报率 | -45.7% | 17.4% |
| 一年总回报 | +20.7% | — |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:BEAM vs VRTX
| 指标 | BEAM | VRTX |
|---|---|---|
| 期末价值 | $14.5K | $22.8K |
| 总回报 | +44.9% | +128.5% |
| 年化收益 (CAGR) | +5.7% | +13.0% |
| 波动率 | 79.5% | 31.9% |
| 夏普比率 | 0.41 | 0.42 |
| 索提诺比率 | 0.63 | 0.57 |
| 最大回撤 | -89.1% | -41.6% |
基于 1696 个共同交易日,2020-02-06 → 2026-11-04 · 无风险利率 4.21%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)